
Zachariah M. DeFilipp, MD, Massachusetts General Hospital
Advertisement
Articles by Zachariah M. DeFilipp, MD, Massachusetts General Hospital
Advertisement
Latest Updated Articles
Risk Factors for Graft-vs-Host DiseasePublished: June 19th 2020 | Updated:
Risk Factors, Incidence & Typical Presentation of GvHDPublished: June 11th 2020 | Updated:
Treatment for Steroid-Refractory GVHD: REACH2Published: June 11th 2020 | Updated:
Special Transplant SituationsPublished: June 19th 2020 | Updated:
GvHD Management RecommendationsPublished: June 11th 2020 | Updated:
Members of the Transplant TeamPublished: June 19th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5






















